Skip to main content
. 2018 Apr 25;2(3):e39. doi: 10.1097/HS9.0000000000000039

Table 2.

Incidence of TEAEs (≥20% of Patients in Any Cohort; Primary and Extension Studies), SAEs (≥2 Patients in Any Cohort; Primary and Extension Studies), and Laboratory Abnormalities (Primary Study Only)

graphic file with name hs9-2-e39-g003.jpg